Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients.

Jérôme René LechienMorgane DucarmeSammy PlaceCarlos-Miguel Chiesa-EstombaMohamad KhalifeGiacomo De RiuLuigi Angelo VairaChristophe de TerwangneShahram MachayekhiArnaud MarchantFabrice JourneSven Saussez

Published in: Pathogens (Basel, Switzerland) (2020)

The prevalence of SLS in severe COVID-19 patients appears to be lower than previously estimated in mild-to-moderate COVID-19 forms. Future comparative studies are needed to explore the predictive value of SLS for COVID-19 severity.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
early onset
risk factors
current status
drug induced